Stock Events

Stock Events

AFT Pharmaceuticals Limited 

$45
11
-$1.13-2.45% Thursday 17:44

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
4.72B
P/E Ratio
0
Dividend Yield
0.02%
Dividend
0.01

Upcoming

18
JUN
Dividend Ex
Estimated
 
3
JUL
Dividend Payment
Estimated
 
18
JUN 27
Dividend Ex
Estimated
 
2
JUL 27
Dividend Payment
Estimated
 

Dividends

0.02%Dividend Yield
Jul 25
$0.01
Jul 24
$0.01
Jul 23
$0.01
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
17.59%
1Y Growth
N/A

Earnings

30JunExpected
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-0.11
-0.07
-0.03
0.01
Expected EPS
0
Actual EPS
-0.1042

Financials

6.99%Profit Margin
Profitable
2017
2018
2019
2020
2021
2022
94.18MRevenue
6.59MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AFTPF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CSL
CSL.AU
Mkt Cap86.6B
CSL Limited is a global biotechnology company that develops and delivers innovative biotherapies and influenza vaccines, competing in similar healthcare sectors as AFT Pharmaceuticals.
Fisher & Paykel Healthcare Limited
FPH.NZ
Mkt Cap0
Fisher & Paykel Healthcare manufactures medical devices and equipment, directly competing with AFT Pharmaceuticals in the healthcare and medical products market in New Zealand and internationally.
Cochlear
COH.AU
Mkt Cap18.78B
Cochlear Limited offers implantable hearing solutions, competing in the broader Australian and global healthcare market where AFT Pharmaceuticals also operates.
Ramsay Health Care
RHC.AU
Mkt Cap7.41B
Ramsay Health Care operates hospitals and surgical centers, competing with AFT Pharmaceuticals in providing healthcare services and products.
Sonic Healthcare
SHL.AU
Mkt Cap10.46B
Sonic Healthcare provides laboratory and diagnostic services, competing in the healthcare sector where AFT Pharmaceuticals offers various pharmaceutical products.
Pro Medicus
PME.AU
Mkt Cap27.55B
Pro Medicus Limited offers medical imaging software and services, competing in the healthcare technology space where AFT Pharmaceuticals is also present.
Ansell
ANN.AU
Mkt Cap5.29B
Ansell Limited specializes in protective industrial and medical gloves, competing in the healthcare supplies market alongside AFT Pharmaceuticals.

About

Information Technology Services
Technology Services
AFT Pharmaceuticals Limited, together with its subsidiaries, develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally. The company offers patented, branded, and generic drugs; and products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, pain management, skin care, vitamins, supplements, gastrointestinal, dermatology, and hospital. It has a research and development collaboration with Belgium's Hyloris Pharmaceuticals to develop a novel innovative injectable iron deficiency therapy. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.
Show more...
CEO
Anthony Mathew Eisen / Nicholas David Molnar
Country
AU
ISIN
NZAFTE0001S4

Listings

NZ
NZ
AFT.NZ
AU
AU
AFP.AU

0 Comments

Share your thoughts

FAQ

What is AFT Pharmaceuticals Limited stock price today?▼
The current price of AFTPF is $45 USD — it has decreased by -2.45% in the past 24 hours. Watch AFT Pharmaceuticals Limited stock price performance more closely on the chart.
What is AFT Pharmaceuticals Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange AFT Pharmaceuticals Limited stocks are traded under the ticker AFTPF.
What is AFT Pharmaceuticals Limited market cap?▼
Today AFT Pharmaceuticals Limited has the market capitalization of 4.72B
What were AFT Pharmaceuticals Limited earnings last quarter?▼
AFTPF earnings for the last quarter are -0.1 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is AFT Pharmaceuticals Limited revenue for the last year?▼
AFT Pharmaceuticals Limited revenue for the last year amounts to 94.18M USD.
What is AFT Pharmaceuticals Limited net income for the last year?▼
AFTPF net income for the last year is 6.59M USD.
Does AFT Pharmaceuticals Limited pay dividends?▼
Yes, AFTPF dividends are paid annual. The last dividend per share was 0.01 USD. As of today, Dividend Yield (FWD)% is 0.02%.
In which sector is AFT Pharmaceuticals Limited located?▼
AFT Pharmaceuticals Limited operates in the Technology sector.
When did AFT Pharmaceuticals Limited complete a stock split?▼
AFT Pharmaceuticals Limited has not had any recent stock splits.
Where is AFT Pharmaceuticals Limited headquartered?▼
AFT Pharmaceuticals Limited is headquartered in Melbourne, AU.